Metropolitan Life Insurance Company (MetLife)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,477
| Closed | -$4.91M | – | 665 |
|
|
2024
Q1 | $4.91M | Sell |
9,477
-87
| -0.9% | -$43.3K | 0.21% | 82 |
|
|
2023
Q4 | $4.51M | Sell |
9,564
-186
| -2% | -$86K | 0.21% | 83 |
|
|
2023
Q3 | $4.25M | Sell |
9,750
-581
| -6% | -$264K | 0.22% | 84 |
|
|
2023
Q2 | $4.59M | Sell |
10,331
-352
| -3% | -$162K | 0.22% | 83 |
|
|
2023
Q1 | $4.91M | Sell |
10,683
-2,571
| -19% | -$1.22M | 0.25% | 78 |
|
|
2022
Q4 | $6.8M | Sell |
13,254
-1,037
| -7% | -$527K | 0.3% | 69 |
|
|
2022
Q3 | $6.49M | Sell |
14,291
-232
| -2% | -$111K | 0.31% | 62 |
|
|
2022
Q2 | $7.01M | Sell |
14,523
-455
| -3% | -$225K | 0.31% | 66 |
|
|
2022
Q1 | $7.36M | Sell |
14,978
-12,815
| -46% | -$5.86M | 0.26% | 76 |
|
|
2021
Q4 | $12.9M | Sell |
27,793
-912
| -3% | -$384K | 0.18% | 96 |
|
|
2021
Q3 | $10.7M | Sell |
28,705
-1,079
| -4% | -$410K | 0.16% | 107 |
|
|
2021
Q2 | $11.4M | Sell |
29,784
-3,919
| -12% | -$1.5M | 0.16% | 102 |
|
|
2021
Q1 | $12.1M | Sell |
33,703
-2,167
| -6% | -$697K | 0.18% | 97 |
|
|
2020
Q4 | $11.5M | Sell |
35,870
-2,216
| -6% | -$680K | 0.17% | 95 |
|
|
2020
Q3 | $10.2M | Sell |
38,086
-1,704
| -4% | -$458K | 0.17% | 100 |
|
|
2020
Q2 | $10.5M | Sell |
39,790
-1,986
| -5% | -$530K | 0.19% | 94 |
|
|
2020
Q1 | $9.48M | Sell |
41,776
-310
| -0.7% | -$84.5K | 0.19% | 96 |
|
|
2019
Q4 | $12.7M | Sell |
42,086
-444
| -1% | -$122K | 0.2% | 88 |
|
|
2019
Q3 | $10.2M | Buy |
42,530
+3,610
| +9% | +$989K | 0.17% | 101 |
|
|
2019
Q2 | $11M | Buy |
38,920
+2,468
| +7% | +$674K | 0.19% | 91 |
|
|
2019
Q1 | $10.5M | Sell |
36,452
-1,171
| -3% | -$339K | 0.19% | 87 |
|
|
2018
Q4 | $9.88M | Buy |
37,623
+92
| +0.2% | +$25.3K | 0.2% | 86 |
|
|
2018
Q3 | $10.3M | Sell |
37,531
-712
| -2% | -$185K | 0.17% | 100 |
|
|
2018
Q2 | $9.1M | Sell |
38,243
-1,270
| -3% | -$294K | 0.15% | 122 |
|
|
2018
Q1 | $8.68M | Buy |
39,513
+109
| +0.3% | +$25.6K | 0.12% | 129 |
|
|
2017
Q4 | $8.87M | Sell |
39,404
-85,372
| -68% | -$18.2M | 0.12% | 125 |
|
|
2017
Q3 | $23.7M | Sell |
124,776
-3,731
| -3% | -$710K | 0.15% | 118 |
|
|
2017
Q2 | $24.2M | Sell |
128,507
-5,959
| -4% | -$1.07M | 0.17% | 115 |
|
|
2017
Q1 | $22.2M | Sell |
134,466
-1,596
| -1% | -$254K | 0.15% | 124 |
|
|
2016
Q4 | $19.6M | Sell |
136,062
-3,266
| -2% | -$437K | 0.14% | 136 |
|
|
2016
Q3 | $17.5M | Sell |
139,328
-1,075
| -0.8% | -$139K | 0.13% | 152 |
|
|
2016
Q2 | $18.4M | Buy |
140,403
+285
| +0.2% | +$39K | 0.14% | 139 |
|
|
2016
Q1 | $19.5M | Sell |
140,118
-2,763
| -2% | -$369K | 0.15% | 127 |
|
|
2015
Q4 | $19.9M | Sell |
142,881
-2,664
| -2% | -$367K | 0.15% | 129 |
|
|
2015
Q3 | $20.4M | Sell |
145,545
-4,156
| -3% | -$625K | 0.15% | 137 |
|
|
2015
Q2 | $24.6M | Sell |
149,701
-606
| -0.4% | -$96.8K | 0.17% | 121 |
|
|
2015
Q1 | $23.2M | Sell |
150,307
-3,643
| -2% | -$519K | 0.17% | 123 |
|
|
2014
Q4 | $19.3M | Sell |
153,950
-3,494
| -2% | -$432K | 0.13% | 148 |
|
|
2014
Q3 | $18.8M | Sell |
157,444
-5,262
| -3% | -$604K | 0.14% | 148 |
|
|
2014
Q2 | $17.5M | Sell |
162,706
-9,676
| -6% | -$997K | 0.12% | 171 |
|
|
2014
Q1 | $17.2M | Sell |
172,382
-10,813
| -6% | -$978K | 0.12% | 174 |
|
|
2013
Q4 | $16.9M | Sell |
183,195
-5,870
| -3% | -$522K | 0.12% | 166 |
|
|
2013
Q3 | $15.8M | Sell |
189,065
-1,828
| -1% | -$157K | 0.12% | 160 |
|
|
2013
Q2 | $15.6M | Buy |
+190,893
| New | +$14.3M | 0.12% | 150 |
|
Other funds holding ELV
Metropolitan Life Insurance Company (MetLife)'s ELV Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 9,477 shares — an estimated $4.91M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ELV in Q2 2013 and held it in 44 quarters. The position peaked at $24.6M in Q2 2015. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 9,477 Elevance Health shares in Q2 2024, an estimated $4.91M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Elevance Health in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Elevance Health position peaked at $24.6M in Q2 2015.
- 1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.